trial

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 2

NCTId NCT05345184
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 51 (actual)
Sponsored by University of Michigan
Primary completion 2025-05-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
51 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2022-09-01
Primary completion
2025-05-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Cognitive Behavioral Suicide Prevention for psychosis (CBSPp)Services as Usual (SAU)

Sponsors

University of MichiganLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Sites

1 total
Ann Arbor, United States

Facts & assertions

4 sourced
Enrollment
51
Phase
NA
Primary Completion Date
2025-05-01
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Behavioral Suicide Prevention for psychosis (CBSPp)
drug
Services as Usual (SAU)
drug
lead_sponsor
University of Michigan
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Psychosis
indication
Psychotic Disorders
indication
Suicide
indication